By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration is currently drafting its plans for regulating laboratory-developed tests and is considering available options, such as using a risk-based approach for oversight and a registry of tests to know what services are available, an FDA official told the Secretary's Advisory Committee for Genetics, Health, and Society today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.